Halt Medical has big plans for its Acessa System for treating uterine fibroids, having raised nearly $93 million in efforts to restructure debt and fund its commercial efforts.
California women's health company Halt Medical is raising capital ahead of a major commercial bid for its Acessa radiofrequency-based uterine fibroid treatment.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1h7TYYM
Cap comentari:
Publica un comentari a l'entrada